Perelman School of Medicine: Gene Therapy Program at Penn Medicine Joins AAVCOVID Vaccine Project
May 29, 2020
May 29, 2020
UNIVERSITY CITY, Pennsylvania, May 29 -- The University of Pennsylvania's Perelman School of Medicine issued the following news release on May 28:
The internationally-renowned Gene Therapy Program at the University of Pennsylvania is joining the AAVCOVID vaccine program led by Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham for the joint research program. AAVCOVID is a unique gene-based vaccine candidate designed to protect against . . .
The internationally-renowned Gene Therapy Program at the University of Pennsylvania is joining the AAVCOVID vaccine program led by Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham for the joint research program. AAVCOVID is a unique gene-based vaccine candidate designed to protect against . . .